These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
516 related items for PubMed ID: 9361185
21. Expression patterns of retinoblastoma and E2F family proteins during corneal development. Francesconi CM, Hutcheon AE, Chung EH, Dalbone AC, Joyce NC, Zieske JD. Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1054-62. PubMed ID: 10752941 [Abstract] [Full Text] [Related]
22. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer. Macaluso M, Cinti C, Russo G, Russo A, Giordano A. Oncogene; 2003 Jun 05; 22(23):3511-7. PubMed ID: 12789259 [Abstract] [Full Text] [Related]
23. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Johnson DG. Oncogene; 1995 Nov 02; 11(9):1685-92. PubMed ID: 7478595 [Abstract] [Full Text] [Related]
24. Changes in E2F DNA-binding activity during induced erythroid differentiation. Richon VM, Venta-Perez G. Cell Growth Differ; 1996 Jan 02; 7(1):31-42. PubMed ID: 8788031 [Abstract] [Full Text] [Related]
25. Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation. Puri PL, Cimino L, Fulco M, Zimmerman C, La Thangue NB, Giordano A, Graessmann A, Levrero M. Cancer Res; 1998 Apr 01; 58(7):1325-31. PubMed ID: 9537223 [Abstract] [Full Text] [Related]
26. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent. Armstrong DJ, Roman A. Virology; 1997 Dec 08; 239(1):238-46. PubMed ID: 9426463 [Abstract] [Full Text] [Related]
27. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter. Araki K, Nakajima Y, Eto K, Ikeda MA. Oncogene; 2003 Oct 23; 22(48):7632-41. PubMed ID: 14576826 [Abstract] [Full Text] [Related]
28. Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth control. Leoncini L, Bellan C, Cossu A, Claudio PP, Lazzi S, Cinti C, Cevenini G, Megha T, Laurini L, Luzi P, Orcioni GF, Piccioli M, Pileri S, Giardino C, Tosi P, Giordano A. Clin Cancer Res; 1999 Dec 23; 5(12):4065-72. PubMed ID: 10632341 [Abstract] [Full Text] [Related]
29. Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Corbeil HB, Whyte P, Branton PE. Oncogene; 1995 Sep 07; 11(5):909-20. PubMed ID: 7675450 [Abstract] [Full Text] [Related]
30. Tumor suppressor proteins as regulators of cell differentiation. Li ZR, Hromchak R, Mudipalli A, Bloch A. Cancer Res; 1998 Oct 01; 58(19):4282-7. PubMed ID: 9766653 [Abstract] [Full Text] [Related]
31. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells. Jori FP, Melone MA, Napolitano MA, Cipollaro M, Cascino A, Giordano A, Galderisi U. Cell Death Differ; 2005 Jan 01; 12(1):65-77. PubMed ID: 15459751 [Abstract] [Full Text] [Related]
32. Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions. Lind EF, Wayne J, Wang QZ, Staeva T, Stolzer A, Petrie HT. J Immunol; 1999 May 01; 162(9):5374-9. PubMed ID: 10228014 [Abstract] [Full Text] [Related]
33. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation. Yamada M, Kondo T, Ashizawa S, Takebayashi T, Higashi H, Hatakeyama M. Cytokine; 2002 Jan 21; 17(2):91-7. PubMed ID: 11886176 [Abstract] [Full Text] [Related]
34. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product. Luo Q, Li J, Cenkci B, Kretzner L. Oncogene; 2004 Feb 05; 23(5):1088-97. PubMed ID: 14716294 [Abstract] [Full Text] [Related]
35. The retinoblastoma-related Rb2/p130 gene is an effector downstream of AP-2 during neural differentiation. Paggi MG, Bonetto F, Severino A, Baldi A, Battista T, Bucci F, Felsani A, Lombardi D, Giordano A. Oncogene; 2001 May 03; 20(20):2570-8. PubMed ID: 11420667 [Abstract] [Full Text] [Related]
36. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts. Liu SL, Rand A, Kelm RJ, Getz MJ. Oncogene; 2000 Jul 13; 19(30):3352-62. PubMed ID: 10918592 [Abstract] [Full Text] [Related]
37. p27kip1-independent cell cycle regulation by MYC. Berns K, Martins C, Dannenberg JH, Berns A, te Riele H, Bernards R. Oncogene; 2000 Oct 05; 19(42):4822-7. PubMed ID: 11039898 [Abstract] [Full Text] [Related]
38. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Wang S, Nath N, Adlam M, Chellappan S. Oncogene; 1999 Jun 10; 18(23):3501-10. PubMed ID: 10376528 [Abstract] [Full Text] [Related]
39. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Hurford RK, Cobrinik D, Lee MH, Dyson N. Genes Dev; 1997 Jun 01; 11(11):1447-63. PubMed ID: 9192872 [Abstract] [Full Text] [Related]
40. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells. Thatikunta P, Raj GV, Kundu M, Khalili K, Amini S. Oncogene; 1997 Jun 19; 14(24):2959-69. PubMed ID: 9205103 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]